Buying $1000 In DGX: If an investor had bought $1000 of DGX stock 5 years ago, it would be worth $963,529.41 today based on a ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But ...

The new DGX machines are portable but powerful enough to drive complex AI modules and research, with processing capabilities ...

At GTC, NVIDIA unveiled major advancements – from the Blackwell Ultra AI platform to advancements in robotics and accelerated computing.

Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET ...

SandboxAQ, a company using quantum-based algorithms and simulations to train AI models, is expanding its existing ...

SandboxAQ today announced a collaboration with NVIDIA across biopharma, chemicals, advanced materials, financial services, cybersecurity, navigation, and medical imaging. SandboxAQ, a member of ...

BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.

While U.S. tariffs are expected to impact Nvidia’s AI server products that are sourced from Taiwan, such products coming from ...

Quest Diagnostics (NYSE:DGX) recently introduced the AD-Detect™ blood test, a significant development aimed at confirming Alzheimer's-related amyloid brain pathology. Over the last quarter ...